Clinical Trial Update: Phase 2 Shigella Vaccine and Challenge [Phase 2]

View source ↗

Summary

Phase 2 trial of a Shigella vaccine has completed and results have been posted. The study was sponsored by the National Institute of Allergy and Infectious Dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shigellosis

Drugs mentioned

• Shigella vaccine (Phase 2 trial)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Immunisation, Shigella Infection | Phase 2 | Status: COMPLETED | Results posted: 2025-04-24